RxDoctor Payments Data

Elizabeth Harding

Physician Assistant · Charleston, SCNPI 1679970271

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $20,238 of the $27,859 with a category attached, or 72.6%. AbbVie accounts for 94.9% of it on its own, with 9 other manufacturers making up the rest. 2025 is the largest year on record at $9,610, 3.9 times the $2,435 reported in 2021. Among physician assistant clinicians in SC with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$27,859in general payments, 2019–2025

Across 165 payments — averaging $168.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$26K
  • Johnson & Johnson$562
  • Lilly USA, LLC$294
  • E.r. Squibb & Sons, L.L.C.$218
  • Bristol Myers Squibb$112
  • Takeda Pharmaceuticals U.S.A., Inc.$99
  • plus $130 from 4 others

What the payments were for

  • Consulting fees$6132%
  • Speaking & faculty fees$20,23873%
  • Travel & lodging$2,0497%
  • Food & beverage$4,95118%
  • Education$90%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$27,859 in reported general payments places this provider in the 95th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$53,257
Medicare patients
137
Services billed
1,054

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
StelaraUstekinumab202$6,617,788
Humira(Cf) PenAdalimumab144$2,741,832
Skyrizi On-BodyRisankizumab-Rzaa27$526,788
CreonLipase/Protease/Amylase56$238,898
RinvoqUpadacitinib24$199,318
Mesalamine114$82,423
Budesonide ErBudesonide16$17,692
LinzessLinaclotide22$16,405
Balsalazide Disodium15$4,009
Azathioprine46$1,883
Mercaptopurine12$1,403
Omeprazole66$1,291
CholestyramineCholestyramine (With Sugar)15$1,204
LoperamideLoperamide Hcl17$895
Esomeprazole Magnesium12$793

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonStelara$562$6,617,788202 claims
AbbVieCreon, Rinvoq, Linzess$26,445$454,621102 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Charleston

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →